Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19.

Caccamo, Nadia; Sullivan, Lucy C; Brooks, Andrew G; Dieli, Francesco

Caccamo, Nadia; Sullivan, Lucy C; Brooks, Andrew G; Dieli, Francesco.

Caccamo N; Central Laboratory for Advanced Diagnosis and Biomedical Research, University of Palermo, Palermo, Italy.
Sullivan LC; Department of Biomedicine, Neuroscience and Advanced Diagnosis, University of Palermo, Palermo, Italy.
Brooks AG; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Dieli F; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Br J Haematol ; 190(4): e185-e187, 2020 08.

Article in English | MEDLINE | ID: covidwho-457530

Subject(s)

CD8-Positive T-Lymphocytes; COVID-19/immunology; Immunotherapy, Adoptive; Lymphocyte Transfusion; SARS-CoV-2/immunology; CD8-Positive T-Lymphocytes/immunology; CD8-Positive T-Lymphocytes/transplantation; COVID-19/therapy; Humans

Keywords

COVID-19; HLA-E-restricted CD8 T cells; SARS-CoV-2; T-cell immunotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphocyte Transfusion / CD8-Positive T-Lymphocytes / SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16895

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google